Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujata Agnani

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Journal of Invasive Cardiology|February 2, 2012
Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosisNuri I Akkus, Saurabh Rajpal, Sujata Agnani
BMC Nephrology|June 16, 2005
Does treating obesity stabilize chronic kidney disease?Sujata Agnani, Vidula T Vachharajani, Rohit Gupta, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Journal of Invasive Cardiology|February 2, 2012
Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosisNuri I Akkus, Saurabh Rajpal, Sujata Agnani
BMC Nephrology|June 16, 2005
Does treating obesity stabilize chronic kidney disease?Sujata Agnani, Vidula T Vachharajani, Rohit Gupta, et al.
Pageof 1